Literature DB >> 23264341

Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.

Tobias Alexander1, Arne Sattler, Lars Templin, Siegfried Kohler, Christian Groß, Andreas Meisel, Birgit Sawitzki, Gerd-Rüdiger Burmester, Renate Arnold, Andreas Radbruch, Andreas Thiel, Falk Hiepe.   

Abstract

OBJECTIVES: Recent data debate the suitability of Helios, an Ikaros family member, as a marker for thymic-derived regulatory T cells (Treg). Nevertheless, Foxp3(+) Helios(+) Treg may be of particular relevance in mediating immune tolerance in chronic autoimmunity, such as systemic lupus erythematosus (SLE), as they possess enhanced suppressive function, compared to Foxp3(+) Helios(-) Treg.
METHODS: Multicolour flow cytometry was performed to analyse Foxp3 and Helios expression in peripheral blood CD4 T cells from SLE patients, compared to healthy controls (HC) and systemic sclerosis (SSc) and rheumatoid arthritis (RA) patients. Cytokine production, chemokine receptor expression for CXCR3 and CCR4, basal signal transducer and activator of transcription 5 (STAT5)a phosphorylation levels and T-cell receptor (TCR) Vβ repertoire were analysed by flow cytometry, and the methylation status of the Foxp3 locus (Treg-specific demethylated region, TSDR) by real-time PCR.
RESULTS: Frequencies of Foxp3(+) Helios(+) Treg, unlike Foxp3(+) Helios(-) T cells, were significantly increased in SLE patients and positively correlated with disease activity, whereas they were unaltered in SSc and RA patients. Compared to HC, Foxp3(+) Helios(+) Treg in SLE predominantly displayed a CD45RA(-)/CD31(-)/FoxP3(low) memory phenotype with increased Ki-67 expression, enhanced basal pSTAT5a levels and a restricted TCR repertoire. Nonetheless, similar to HC, Foxp3(+) Helios(+) Treg in SLE lacked effector cytokine production, possessed a highly demethylated TSDR and expressed comparable levels of CXCR3 and CCR4.
CONCLUSIONS: Our data suggest that Helios-expressing Foxp3(+) Treg with functional suppressive capacity and migratory potential into inflamed tissues are expanded in active SLE, presumably through γ-chain signalling cytokines and TCR stimulation, to compensate for autoreactive effector responses.

Entities:  

Keywords:  Autoimmune Diseases; Autoimmunity; Systemic Lupus Erythematosus; T Cells

Mesh:

Substances:

Year:  2012        PMID: 23264341     DOI: 10.1136/annrheumdis-2012-202216

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  62 in total

1.  Effects of aging on human leukocytes (part II): immunophenotyping of adaptive immune B and T cell subsets.

Authors:  Ulrik Stervbo; Cecilia Bozzetti; Udo Baron; Karsten Jürchott; Sarah Meier; Julia Nora Mälzer; Mikalai Nienen; Sven Olek; Dominika Rachwalik; Axel Ronald Schulz; Avidan Neumann; Nina Babel; Andreas Grützkau; Andreas Thiel
Journal:  Age (Dordr)       Date:  2015-09-02

2.  Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

3.  OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Authors:  Clément Jacquemin; Jean-François Augusto; Marc Scherlinger; Noémie Gensous; Edouard Forcade; Isabelle Douchet; Emeline Levionnois; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Marie-Elise Truchetet; Julien Seneschal; Lionel Couzi; Jean-Luc Pellegrin; Jean-François Viallard; Thierry Schaeverbeke; Virginia Pascual; Cécile Contin-Bordes; Patrick Blanco
Journal:  JCI Insight       Date:  2018-12-20

4.  Interleukin-2 treatment reverses effects of cAMP-responsive element modulator α-over-expressing T cells in autoimmune-prone mice.

Authors:  K Ohl; A Wiener; A Schippers; N Wagner; K Tenbrock
Journal:  Clin Exp Immunol       Date:  2015-05-14       Impact factor: 4.330

5.  Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Carley Demchuk; Steven Montner; Rekha Vij; Mary E Strek
Journal:  Respir Med       Date:  2016-03-21       Impact factor: 3.415

6.  [Pathogenesis of systemic lupus erythematosus].

Authors:  T Alexander; A Radbruch; F Hiepe
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

Review 7.  Emerging cell and cytokine targets in rheumatoid arthritis.

Authors:  Gerd R Burmester; Eugen Feist; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2013-11-12       Impact factor: 20.543

Review 8.  New insights into the epigenetics of inflammatory rheumatic diseases.

Authors:  Esteban Ballestar; Tianlu Li
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

9.  Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.

Authors:  Melissa E Munroe; Evan S Vista; Joel M Guthridge; Linda F Thompson; Joan T Merrill; Judith A James
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

Review 10.  [Regulatory T-cells in systemic lupus erythematosus. IL-2 is decisive for loss of tolerance].

Authors:  K Ohl; K Tenbrock
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.